Monday, December 17, 2018
EyePoint added to Nasdaq Biotechnology Index
EyePoint Pharmaceuticals (EYPT) announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI). EyePoint’s addition to the NBI will become effective prior to market open on Monday, December 24, 2018.
https://thefly.com/landingPageNews.php?id=2838241
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.